CAR T-cells expressing o9R and receiving orthogonal IL-2 also exhibited greater anti-tumor activity in syngeneic mouse models compared to CAR T-cells expressing the orthogonal IL-2 receptor (73). The gene discussed is IL2; the disease is neoplasm.